Actively Recruiting
Personalized Targeted Treatments for Childhood and Adolescent Cancers Using Tumor Genetic Profiles Phase 1 and 2 Study of Novel Drug Combinations Including Paxalisib and Opdualag
Led by Australian & New Zealand Children's Haematology/Oncology Group · Updated on 2026-01-28
90
Participants Needed
14
Research Sites
260 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating new targeted treatments for childhood and adolescent cancers through a companion platform trial called OPTIMISE. This trial links patients to experimental therapies based on detailed genetic profiling of their tumors, focusing on common genetic changes found in pediatric cancers. The trial aims to test novel combination therapies regardless of tumor type, seeking to improve clinical outcomes by matching treatments to tumor profiles. The trial includes multiple treatment groups with different drug combinations. One group receives Irinotecan intravenously on days 1 to 5, Temozolomide orally on days 1 to 5, and Paxalisib orally daily all given in 28-day cycles for up to 13 cycles. Another group receives Opdualag, a fixed-dose combination of Nivolumab and Relatlimab, given intravenously on day 1 every 28 days for up to 26 cycles. Each treatment group is focused on targeting specific pathways identified in the patients tumors. Participants will undergo regular assessments including disease evaluations and laboratory tests, which may be performed at their local oncology centers. Researchers will monitor treatment effects, measure tumor responses, and evaluate safety over several years. The study tracks outcomes such as the number of patients treated, recommended doses, response rates, clinical benefit, progression-free survival, and adverse events. Participation involves follow-up for up to five years to assess how well these targeted therapies work and their safety.
CONDITIONS
Brief Title
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
Research Team
I
International Study Coordinator
I
International Study Manager
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here